Suggested Use

One capsule three times daily, or as otherwise directed by a health-care practitioner.

Nutrition Info

Ingredients One Capsule Contains: Curcumin Phytisome (root) (Curcuma longa extract / Phosphatidylcholine complex) 250 mg Other Ingredients: High and low viscosity hydroxypropyl methyl-cellulose and CalciumCitrateLaurate, Hypromellose (derived from cellulose) capsule, Leucine, Silicon Dioxide, Microcrystalline Cellulose. Curcumin Phytosome (Meriva®) complexed with Time-Sorb® – a patent-pending, time-release matrix. Meriva® (Curcumin Phytosome) is a registered trademark of Indena S.p.A. Contains ingredient derived from soy (phytosome). Suggested Use: One capsule three times daily, or as otherwise directed by a health-care practitioner.

Description

Product Information Meriva-SR is a unique, patented time-release curcumin product available exclusively from Thorne Research. People throughout Asia have benefited from the healthful effects of curcumin for centuries. Curcumin is the orange pigment in turmeric (the primary ingredient in curry), and is a potent antioxidant that offers numerous health benefits, including supporting joint health and cardiovascular function, and helping to maintain the body's normal inflammatory response.* Whether taken as a supplement or from food, curcumin is generally poorly absorbed into the bloodstream. In conjunction with Indena S.p.A., the worldwide experts in botanical extract technology, we have uncovered the key to curcumin absorption - phytosome technology. Meriva Curcumin Phytosome is a unique curcumin extract that is significantly better absorbed than other curcumin extracts. Phytosomes are plant extracts bound to phosphatidylcholine (PC), an essential component of human cells. Our bodies can make PC, but we can also get it from food or supplements. When taken orally, PC is very well absorbed. The scientists at Indena found a way to attach a curcumin extract to PC for superior absorption, resulting in Meriva. When you take Meriva your body absorbs the PC and the attached curcumin, resulting in more curcumin reaching the cells that can benefit from it.* A 2007 study published in the journal, Cancer Chemotherapy and Pharmacology, demonstrated Meriva's superior bioavailability compared to ordinary curcumin. This animal study indicated a significantly greater plasma concentration time curve, with an area under the curve (AUC) five times higher for Meriva. Liver levels of curcumin were also higher with Meriva supplementation. A recent human study (not yet published) demonstrated even greater bioavailability. Meriva supplementation resulted in significantly better absorption, with better plasma concentrations of curcumin from a much smaller dose than with ordinary curcumin. Several studies have illustrated curcumin's hepatoprotective effects, leading researchers to suggest its use in protecting the liver from exogenous insults from environmental toxins, such as acetaminophen and carbon tetrachloride.* Curcumin also has the capacity to increase both the flow and solubility of bile.* Curcumin's hepatoprotective effects are due in part to direct free-radical scavenging; but curcumin also enhances the body's natural antioxidant system, which increases glutathione levels, thereby aiding in hepatic detoxification and inhibiting nitrosamine formation.*

Note

Warnings ALLERGY WARNINGS This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients. Meriva-SR contains curcumin phytosome - a plant extract complexed with phosphatidylcholine, which is derived from soy. Phosphatidylcholine contains no soy protein. There are no other soy-based ingredients in Meriva-SR. EXCIPIENT FREE This product does not contain wheat, gluten, corn, yeast, egg, dairy products, or artificial colors, sweeteners, or flavors. This product also does not contain lactose, palmitic acid, or magnesium, calcium, or vegetable stearates. PREGNANCY WARNING If pregnant, consult your health-care practitioner before using this product. INTERACTIONS/CONTRAINDICATIONS Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided